Nuclear medicine procedures for the diagnosis of acute and chronic renal failure

Nephron - Clinical Practice

Volumn 103, Issue 2, 2006, Pages

  Haufe, Sabine E ^a   Riedmuller K ^a   Haberkorn, U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Radiotracer; Renal failure; Renal scintigraphy

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 4 AMINOHIPPURIC ACID; AMMONIA N 13; ANESTHETIC AGENT; ANGIOTENSIN RECEPTOR; ANTIBIOTIC AGENT; CALCINEURIN INHIBITOR; CONTRAST MEDIUM; DIAMINOCYCLOHEXANE TC 99M; FLUOROAZOYCINARABINOFURANOSIDE F 18; FUROSEMIDE; IODINE 131; IODOHIPPURATE SODIUM I 131; MERTIATIDE TC 99M; NONSTEROID ANTIINFLAMMATORY AGENT; PENTETATE TECHNETIUM TC 99M; PYRUVALDEHYDE BIS(N 4 METHYLTHIOSEMICARBAZONATO) CU 64; RADIOISOTOPE; RUBIDIUM 82; SUCCIMER TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG; WATER O 15;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; BLOOD VESSEL OCCLUSION; CHEMOTHERAPY; CHRONIC KIDNEY FAILURE; DIAGNOSTIC ACCURACY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG UPTAKE; ENZYME ACTIVITY; EVALUATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY SCINTISCANNING; NONHUMAN; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; TOXICITY;

HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; NUCLEAR MEDICINE;

EID: 33645004418     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091576     Document Type: Review

References (24)

1. Hosten AO: Hemodynamic basis for human acute renal failure. J Natl Med Assoc 1976;68:172-176.
2. Fritzberg AR, Kasina S, Eshima D, Johnson DL: Synthesis and biological evaluation of technicium-99m MAG3 as a hippuran replacement. J Nucl Med 1986;27:111-116.
3. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function. Ann Nucl Med 2001;15:179-190.
4. Bubeck B, Brandau W, Weber E, Kalble T, Parekh H, Georgi P: Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med 1990;31:1285-1293.
5. Brown SC, Upsdell SM, O'Reilly PH: The importance of renal function in the interpretation of diuresis renography. Br J Urol 1992;69:121-125.
6. 99mTc-MAG3 renogram: a dramatic reversible consequence of contrast nephrotoxicity superimposed on renal obstruction. Br J Radiol 2005;78:349-352.
7. Dhawan RT, Foo M, Bomanji JB, Setna FL, Ell PJ: Contract nephrotoxicity and the role of radionuclide renal scan. J Nucl Med 1996;37:1828-1830.
8. Bender WL, Whelton A, Beschorner WE, Darwish MO, Hall-Craggs M, Solez K: Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of inflammatory mfiltrate. Am J Med 1984;76:1006-1012.
9. Esteves FP, Halkar RK, Taylor A: Transureteroureterostomy obstruction mimicking acute tubular necrosis. Clin Nucl Med 2002;27:109-112.
10. Hilson AJ, Maisey MN, Brown CB, Ogg CS, Bewick MS: Dynamic renal transplant imaging with Tc-99m-DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med 1987;19:994-1000.
11. 99mTc-chelate substitute for organoradiomercurial renal agents. J Nucl Med 1974;15:34-35.
12. Rossleigh MA, Farnsworth RH, Leighton DM, Yong JL, Rose M, Christian CL: Technetium-99m dimercaptosuccinic acid scintigraphy studies of renal cortical scarring and renal length. J Nucl Med 1998;39:1280-1285.
13. Bockisch A, Beyer T, Antoch G, et al: Positron emission tomography/computed tomography - image protocols, artifacts, and pitfalls. Mol Imaging Biol 2004;6:188-199.
14. Young H, Carnochan P, Zweit J, et al: Evaluation of copper(II)- pyruvaldehyde bis(N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model. Eur J Nucl Med 1994;21:336-341.
15. Killion D, Nitzsche E, Choi Y, et al: Positron emission tomography: a new method for determination of renal function. J Urol 1993;150:1064-1068.
16. 55Co-EDTA for renal imaging using positron emission tomography: a feasibility study. Nucl Med Biol 2000;27:77-81.
17. Sonmezoglu K, Erdil TY, Demir M, et al: Evaluation of renal function in low dose cyclosporine-treated patients using technetium-99m diaminocyclohexane: a cationic tubular excretion agent. Eur J Nucl Med 1998;25:1630-1636.
18. Hwang DR, Eckelman WC, Mathias CJ, et al: Positron-labeled angiotensin-converting enzyme Inhibitor (ACE): fluorine-18-fluorocaptopril. Probing ACE activity in vivo by positron emission tomography. J Nucl Med 1991;32:1730-1737.
19. Mathews WB, Yoo SE, Lee SH, et al: A novel radioligand for imaging the AT1 angjotensin receptor with PET. Nucl Med Biol 2004;31:571-574.
20. Szabo Z, Speth RC, Brown PR, et al: Use of positron emission tomography to study AT1 receptor regulation in vivo. J Am Soc Nephrol 2001;12:1350-1358.
21. I8F]-fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 2003;30:317-326.
22. 18F-galacto-RGD in cancer patients. J Nucl Med 2005;46:1333-1341.
23. Rosenberger C, Griethe W, Gruber G, et al: Cellular responses to hypoxia after renal segmental infarction. Kidney Int 2003;64:874-886.
24. Goligorsky MS, DiBona GF: Pathogenetic role of Arg-Gly-Asp-recognizing integrins in acute renal failure. Proc Natl Acad Sci USA 1993;90:5700-5704.